NCT04408196

Brief Summary

Coronavirus disease (COVID-19) is caused by the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) virus. This virus was identified in December 2019 in the Chinese city of Wuhan, in the province of Hubei, where it determined a state of health emergency proclaimed by China on January 30, 2020. Since February 2020, Italy has been involved in the emergency of the COVID-19 infection, with devastating consequences for the health of the population and the economy of our country. As published by the Italian National Institute of Health, the starting date of the symptoms dates back to the end of January, the first case diagnosed dates back to 21 February 2020 while the first cases of home isolation date back to March 1st, 2020. On March 30, 2020, there were 101739 positive subjects and 11591 deaths (Civil Protection data). According to data published by the World Health Organization, most people with COVID-19 develop a flu-like form, 14% develop a severe form that requires hospitalization and oxygen therapy and 5% require an ICU admission. The emergency from Covid19 made it necessary to provide institutional social distancing conditions which resulted in rehabilitation departments being prohibited from visiting patients by family members and/or caregivers. This event, although necessary, led to the first moment of discomfort on the part of patients and family members; to overcome this reaction "technological" solutions were found, trying to give continuity to the contact between the patient and the family member through the use of video calls. Despite this, the COVID-19 emergency and the limitations resulting from social distancing likely have an impact on both patients and family members/caregivers that needs to be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2020

Completed
5 days until next milestone

Study Start

First participant enrolled

May 26, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 29, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2021

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 22, 2021

Completed
Last Updated

April 7, 2022

Status Verified

March 1, 2022

Enrollment Period

9 months

First QC Date

May 21, 2020

Last Update Submit

March 29, 2022

Conditions

Keywords

rehabilitation

Outcome Measures

Primary Outcomes (9)

  • Short Form-36 Health Survey (SF36)

    It is a questionnaire to evaluate the Quality of Life

    After one month of hospitalisation (baseline, T0)

  • Short Form (36) Health Survey (SF36)

    It is a questionnaire to evaluate the Quality of Life

    One month after baseline (T1)

  • Short Form (36) Health Survey (SF36)

    It is a questionnaire to evaluate the Quality of Life

    Two months after baseline (T2)

  • Beck Anxiety Inventory (BAI)

    It is a brief, criteria-referenced assessment for measuring anxiety severity and level

    After one month of hospitalisation (baseline,T0)

  • Beck Anxiety Inventory (BAI)

    It is a brief, criteria-referenced assessment for measuring anxiety severity and level

    One month after baseline (T1)

  • Beck Anxiety Inventory (BAI)

    It is a brief, criteria-referenced assessment for measuring anxiety severity and level

    Two months after baseline (T2)

  • Beck Depression Inventory-II (BDI-II)

    It is a brief, criteria-referenced assessment for measuring depression severity

    After one month of hospitalisation (baseline)

  • Beck Depression Inventory-II (BDI-II)

    It is a brief, criteria-referenced assessment for measuring depression severity

    One month after baseline (T1)

  • Beck Depression Inventory-II (BDI-II)

    It is a brief, criteria-referenced assessment for measuring depression severity

    Two months after baseline (T2)

Secondary Outcomes (1)

  • modified Barthel Index (mBI)

    After one month of hospitalisation (baseline, T0)

Study Arms (2)

Patients

100 patients admitted to an inpatient rehabilitation facility

Caregivers

100 caregivers of patients admitted to an inpatient rehabilitation facility

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to inpatients rehabilitation centers Caregivers of patients admitted to inpatients rehabilitation centers

You may qualify if:

  • patients admitted to the centers of the Don Gnocchi Foundation participating in the study and their caregivers will be recruited

You may not qualify if:

  • For patients: a score on the Mini-Mental State Examination (MMSE) scale lower than 24 which prevents the administration of SF36;
  • For patients and caregivers: failure to acquire informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Don Gnocchi Foundation

Rome, 00168, Italy

Location

Related Publications (2)

  • Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998 Nov;51(11):1025-36. doi: 10.1016/s0895-4356(98)00094-8.

    PMID: 9817120BACKGROUND
  • Aprile I, Piazzini DB, Bertolini C, Caliandro P, Pazzaglia C, Tonali P, Padua L. Predictive variables on disability and quality of life in stroke outpatients undergoing rehabilitation. Neurol Sci. 2006 Apr;27(1):40-6. doi: 10.1007/s10072-006-0563-5.

    PMID: 16688598BACKGROUND

Study Officials

  • Irene APRILE, MD,PHD

    IRCCS Fondazione Don Carlo Gnocchi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Md, PhD, Principal Investigator, Head of Rehabilitation Unit

Study Record Dates

First Submitted

May 21, 2020

First Posted

May 29, 2020

Study Start

May 26, 2020

Primary Completion

February 15, 2021

Study Completion

February 22, 2021

Last Updated

April 7, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations